Literature DB >> 16750861

Functional characterization of OX40 expressed on human CD8+ T cells.

Tomoko Fujita1, Naoya Ukyo, Toshiyuki Hori, Takashi Uchiyama.   

Abstract

In the present study, we investigated the expression of OX40 on human CD8(+) T cells with regard to expression induction, costimulatory function and possible involvement in cytotoxicity. Human CD8(+) T cells were purified from peripheral blood mononuclear cell (PBMC) of healthy donors and cocultured with allogeneic monocyte-derived dendritic cells. Flow cytometric analysis showed that expression of OX40 was induced on CD8(+) T cells within 1 day and increased to the maximum levels on day 3. An addition of anti-OX40 ligand (OX40L) mAb suppressed CD25 expression, proliferation and IFN-gamma production of CD8(+) T cells, suggesting that OX40 functions as a costimulatory molecule not only for CD4(+) T cells but also for CD8(+) T cells. In parallel, coculture of pre-activated CD8(+) T cells with OX40L-transfected murine epithelial cells (MMCE-OX40L) resulted in an increase in CD25 expression, proliferation and IFN-gamma producing cells, compared with that with the mock control (MMCE-mock). Finally, non-specific cytotoxic activity of preactivated CD8(+) T cells was examined using OKT3 hybridoma as target cells after coculture with these transfectants. Coculture with MMCE-OX40L induced slightly higher cytotoxicity of CD8(+) T cells than that with MMCE-mock. These results indicate that OX40 is induced transiently on CD8(+) T cells upon activation and its signals contribute to both clonal expansion and functional reinforcement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750861     DOI: 10.1016/j.imlet.2006.04.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  17 in total

Review 1.  T-cell activation in the intestinal mucosa.

Authors:  Dina Montufar-Solis; Tomas Garza; John R Klein
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

2.  Separation of plasma-derived exosomes into CD3(+) and CD3(-) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients.

Authors:  M-N Theodoraki; T K Hoffmann; T L Whiteside
Journal:  Clin Exp Immunol       Date:  2018-03-12       Impact factor: 4.330

3.  Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.

Authors:  Yan Yang; Chengwen Liu; Weiyi Peng; Gregory Lizée; Willem W Overwijk; Yang Liu; Scott E Woodman; Patrick Hwu
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

4.  Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection.

Authors:  Shahram Salek-Ardakani; Magdalini Moutaftsi; Alessandro Sette; Michael Croft
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis.

Authors:  Kendra Garrison; Tobias Hahn; Wen-Cherng Lee; Leona E Ling; Andrew D Weinberg; Emmanuel T Akporiaye
Journal:  Cancer Immunol Immunother       Date:  2011-10-05       Impact factor: 6.968

Review 6.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

7.  Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma.

Authors:  Xiaoru Sun; Lu Wang; Hongkai Li; Chuandi Jin; Yuanyuan Yu; Lei Hou; Xinhui Liu; Yifan Yu; Ran Yan; Fuzhong Xue
Journal:  Aging (Albany NY)       Date:  2021-06-16       Impact factor: 5.682

Review 8.  The significance of OX40 and OX40L to T-cell biology and immune disease.

Authors:  Michael Croft; Takanori So; Wei Duan; Pejman Soroosh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 9.  Airway smooth muscle in asthma: just a target for bronchodilation?

Authors:  Judith L Black; Reynold A Panettieri; Audreesh Banerjee; Patrick Berger
Journal:  Clin Chest Med       Date:  2012-07-11       Impact factor: 2.878

10.  Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; O Brad Spiller; Pascal Schneider; Margaret J Hosie
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.